DelveInsight’s ‘Pruritus in Atopic Dermatitis – Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Pruritus in Atopic Dermatitis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Atopic Dermatitis as well as Pruritus in Atopic Dermatitis from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Geography Covered
• The United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan

Study Period: 2016-2027

Pruritus in Atopic Dermatitis – Disease Understanding and Treatment Algorithm
The DelveInsight “Pruritus in Atopic Dermatitis” report gives the thorough understanding of the Pruritus in Atopic Dermatitis by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Pruritus in Atopic Dermatitis in the US, Europe, and Japan.

Pruritus in Atopic Dermatitis Epidemiology
The Pruritus in Atopic Dermatitis epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.
The disease epidemiology covered in the report is segmented by prevalent population of Atopic Dermatitis, Atopic Dermatitis by Severity [mild, moderate & severe], AD by Pruritus burden, AD by Pruritus Severity [Moderate to Severe], Uncontrolled Atopic Dermatitis [Children & Adults] in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
According to DelveInsight, the prevalent population of Pruritus in Atopic Dermatitis in 7 major markets was estimated to be 20.58 Million [7MM] in 2016 and, is expected to increase with a significant growth rate from 2016-2027. United States accounts for the highest Cases, followed by EU5 (Germany, France, Italy, Spain & UK) and Japan. Among EU5, Germany has been reported to have the highest prevalent population of pruritus in atopic dermatitis.

Pruritus in Atopic Dermatitis Drug Chapters
This segment of the Pruritus in Atopic Dermatitis report encloses the detailed analysis of marketed drugs and late stage (Phase-III & Phase-II) pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
The upcoming therapies for the treatment of Pruritus in Atopic Dermatitis mainly include [Nemolizumab (Galderma Pharma), Tralokinumab (LEO Pharma), Tradipitant (Vanda Pharmaceuticals), ZPL-389 (Novartis), NST-141 (Nippon Shinyaku), etc., have been covered in the report.

Pruritus in Atopic Dermatitis Market Outlook
The Pruritus in Atopic Dermatitis market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the global market of Pruritus in Atopic Dermatitis was estimated to be USD 1.8 billion in 2016, and is expected to increase with a significant growth rate from 2016-2027.

Pruritus in Atopic Dermatitis Drugs Uptake
This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2016-2027. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.
This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Key Benefits
• This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving the Pruritus in Atopic Dermatitis market
• Organize sales and marketing efforts by identifying the best opportunities for Pruritus in Atopic Dermatitis market
• To understand the future market competition in the Pruritus in Atopic Dermatitis market.

Figure 1: Risk Factors for Pruritus in Atopic Dermatitis
Figure 2: Pathophysiology of Pruritus in Atopic Dermatitis
Figure 3: Mediators involved in Pathophysiology of Pruritus in Atopic Dermatitis
Figure 4: Mediators with their mechanism of action in inducing Pruritus in atopic Dermatitis
Figure 5: Triggering factors involved in pathophysiology of Pruritus in Atopic Dermatitis
Figure 6: Total Prevalent Population of Atopic Dermatitis in 7 MM (2016-2027)
Figure 7: Total Prevalent Population of Atopic Dermatitis by Severity in 7 MM (2016-2027)
Figure 8: Total Prevalent Population of Atopic Dermatitis by Pruritus Burden in 7 MM (2016-2027)
Figure 9: Prevalent Population of Atopic Dermatitis by Pruritus Burden in the United States (2016-2027)
Figure 10: Prevalent Population of Atopic Dermatitis by Pruritus Burden in Germany (2016-2027)
Figure 11: Prevalent Population of Atopic Dermatitis by Pruritus Burden in France (2016-2027)
Figure 12: Prevalent Population of Atopic Dermatitis by Pruritus Burden in Italy (2016-2027)
Figure 13: Prevalent Population of Atopic Dermatitis by Pruritus Burden in Spain (2016-2027)
Figure 14: Prevalent Population of Atopic Dermatitis by Pruritus Burden in the UK (2016-2027)
Figure 15: Prevalent Population of Atopic Dermatitis by Pruritus Burden in Japan (2016-2027)
Figure 16: Prevalent Cases of Atopic Dermatitis by Pruritus Severity in Moderate to Severe Cases in 7MM (2016-2027)
Figure 17: Total Prevalent Population with Uncontrolled Atopic Dermatitis in 7 MM (2016-2027)
Figure 18: Total Prevalent Population with Uncontrolled Atopic Dermatitis in Children and Adults in 7 MM (2016-2027)
Figure 19: General Treatment for Pruritus in Atopic Dermatitis
Figure 20: First Line of treatment for Pruritus in Atopic Dermatitis
Figure 21: Second Line of treatment for Pruritus in Atopic Dermatitis
Figure 22: Current Unmet Need for Pruritus in Atopic Dermatitis
Figure 23: 7 Major Market Size of Atopic Dermatitis in USD Million (2016-2027)
Figure 24: 7 Major Market Size of Pruritus in Atopic Dermatitis in USD Million (2016-2027)
Figure 25: Market Size of Pruritus in Atopic Dermatitis in United States, USD Millions (2016-2027)
Figure 26: Market Size of Pruritus in Atopic Dermatitis in Germany , USD Million (2016-2027)
Figure 27: Market Size of Pruritus in Atopic Dermatitis in France, USD Million (2016-2027)
Figure 28: Market Size of Pruritus in Atopic Dermatitis in Italy, USD Million (2016-2027)
Figure 29: Market Size of Pruritus in Atopic Dermatitis in Spain, USD Million (2016-2027)
Figure 30: Market Size of Pruritus in Atopic Dermatitis in United Kingdom , USD Million (2016-2027)
Figure 31:Market Size of Pruritus in Atopic Dermatitis in Japan , USD Million (2016-2027)

アトピー性皮膚炎（AD）の世界市場インサイト・疫学分析・市場予測DelveInsight’s ‘Atopic Dermatitis - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Atopic Dermatitis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Atopic Dermatitis from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess...

アトピー性皮膚炎（AD）の疫学予測DelveInsight’s ‘Atopic Dermatitis - Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Atopic Dermatitis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. Geography Covered • The United States • EU5 (Germany, France, Italy, Spain and the United Kingdom) • Japan Study Period: 2016-2027 Atopic Dermatitis Epidemiology The Atopic Dermatitis (AD) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Atopic Dermatitis are studied through all possible division to give a better...

アトピー性皮膚炎の疫学的予測（～2024）EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2024 Summary Atopic dermatitis or atopic eczema is the most common type of eczema. Atopic dermatitis is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children. Risk factors for atopic dermatitis are broadly classified as modifiable and non-modifiable. Modifiable risk factors include inhalant allergens, food allergens, and newborns not being exclusively breastfed; non-modifiable risk factors include young age and genetics or heritability. In addition, the most common comorbidities associated with the atopic dermatitis...

尿失禁治療薬の世界市場：市場インサイト、疫学分析、市場予測DelveInsight’s “Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023-7MM” Reports provides an overview of the disease and global market size of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023. Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage function of the lower urinary tract and loss of bladder control resulting in leakage of urine. Embarrassment, isolation, and depression are observed among patients with Urinary Incontinence. Millions of individuals worldwide...

子宮内膜症の世界市場インサイト・疫学分析・市場予測DelveInsight’s ‘Endometriosis - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Endometriosis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Endometriosis from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of...

ヒトサイトメガロウイルス（CMV）感染症治療薬の世界市場：市場インサイト、疫学分析、市場予測DelveInsight’s “Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023” Report provides an overview of the disease and market size of the CMV for theglobal, United States, EU5 (France, Germany, Italy, Spain and United Kingdom) and Japan for 2013-2023. It also includes global historical and forecasted epidemiological data for the CMV Prevalent, Diagnosed and Treatable Cases, CMV Patients among Transplants, Infants Patients at High Risk of CMV and HIV Patients at High Risk of CMVfrom 2013-2023. According to DelveInsight, the Global Diagnosed cases for Cytomegalovirus (CMV) Infection are expected to increase at a CAGR of 0.047% to 172,864 cases...

全身性エリテマトーデス（SLE）の世界市場インサイト・疫学分析・市場予測DelveInsight’s ‘Systemic Lupus Erythematosus (SLE) - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of SLE in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Systemic Lupus Erythematosus (SLE) from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the...

アトピー性皮膚炎（AD）治療薬の世界市場：市場インサイト、疫学、市場予測 Note*: This report requires 7-10 business days to complete. DelveInsight’s Atopic dermatitis (AD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Atopic dermatitis (AD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Atopic dermatitis (AD) till 2023. Key Coverage and...

多発性硬化症(MS)の世界市場インサイト・疫学分析・市場予測DelveInsight’s ‘Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Multiple Sclerosis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Multiple Sclerosis from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess...

肺動脈性肺高血圧症（PAH）の世界市場インサイト・疫学分析・市場予測DelveInsight’s ‘Pulmonary Arterial Hypertension (PAH)- Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of PAH in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Pulmonary Arterial Hypertension (PAH) from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities...

ぶどう膜炎の世界市場インサイト・疫学分析・市場予測DelveInsight’s ‘Uveitis - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Uveitis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Uveitis from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of...

ヒトサイトメガロウイルス（CMV）感染症治療薬のアメリカ市場：市場インサイト、疫学分析、市場予測DelveInsight’s “Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023-United States” Report provides an overview of the disease and market size of the CMV for United States. It also includes historical and forecasted epidemiological data for the CMV Prevalent, Diagnosed and Treatable Cases, CMV Patients among Transplants, Infants Patients at High Risk of CMV and HIV Patients at High Risk of CMV from 2013-2023.As per DelveInsight’s estimation, the total number of Diagnosed CMV Infection cases in United States is expected to increase at a CAGR of 0.041% to 77,726 cases in 2023. The US market size of Cytomegalovirus (CMV)...

アトピー性皮膚炎治療薬の世界市場予測および分析（～2024）PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2024 Summary Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit. By the mid-to-late term of GlobalData’s 2014 to 2024 forecast, Sanofi/Regeneron’s dupilumab is expected to reshape the adult moderate and severe treatment landscape and to slowly enter the market for younger patients with milder forms of the disease. Other events that are expected...

ヒトサイトメガロウイルス（CMV）感染症治療薬の日本市場：市場インサイト、疫学分析、市場予測DelveInsight’s “Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023-Japan” Report provides an overview of the disease and market size of the CMV for Japan. It also includes historical and forecasted epidemiological data for the CMV Prevalent, Diagnosed and Treatable Cases, CMV Patients among Transplants, Infants Patients at High Risk of CMV and HIV Patients at High Risk of CMV from 2013-2023.According to DelveInsight, the total number of Diagnosed Cytomegalovirus (CMV) Infection cases is expected to increase at a CAGR of 0.056% to7,355 cases in 2023. Out of all these high risk categories, Infants have comparatively higher number of...

アルファ-アンチトリプシン欠乏症の世界市場インサイト・疫学分析・市場予測DelveInsight’s ‘Alpha- Antitrypsin Deficiency (AATD) - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology trends in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of AATD from 2016 to 2027 segmented by the US, EU-5 countries and Rest of the World (RoW). The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess...